Additional Information for Pancrelipase Deleayed-Release Capsules
Pancrelipase Delayed-Release Capsules are a type of medication that falls under the supply class of Drugs And Biologicals in the supply group of Medical, Dental, And Veterinary Equipment And Supplies.
Pancrelipase is an enzyme replacement therapy used to treat pancreatic enzyme deficiency, which can occur in conditions such as cystic fibrosis, chronic pancreatitis, and pancreatic cancer. These capsules contain a combination of enzymes, including lipase, protease, and amylase, which help in the digestion of fats, proteins, and carbohydrates.
The delayed-release formulation of the capsules ensures that the enzymes are released in the small intestine, where they are needed for proper digestion. This helps improve nutrient absorption and can alleviate symptoms such as malabsorption, steatorrhea (excessive fat in the stool), and weight loss.
Pancrelipase Delayed-Release Capsules are typically prescribed by healthcare professionals and should be taken with meals or snacks, as directed. The dosage may vary depending on the individual's condition and response to treatment.
It is important to note that Pancrelipase Delayed-Release Capsules are a prescription medication and should only be used under the guidance of a healthcare professional.
Related Item Names for INC 66747 Pancrelipase Deleayed-Release Capsules
NATO Stock Numbers with Item Name 66747 Pancrelipase Deleayed-Release Capsules Page 1 of 1
- NDC58177-0050-04
- RNCC: 5 | RNVC: 2 | DAC: 4
- NDC00045-0343-60
- RNCC: 5 | RNVC: 9 | DAC: 4
- NDC00045-0342-60
- RNCC: 3 | RNVC: 9 | DAC: 4
- NDC00045-0341-60
- RNCC: 3 | RNVC: 9 | DAC: 4
- NDC00045-0095-60
- RNCC: 3 | RNVC: 9 | DAC: 6
- PANCREASE CAPSULES
- RNCC: 5 | RNVC: 1 | DAC: 4